Post on 22-Mar-2022
transcript
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
Product identity: 1200mg Delta8+CBG Oil - Chocolate Lot 040921.D8MC.PK1Client/Metrc ID: .
Customer:
04/26/21 09:30Sample Date:21-004683-0001Laboratory ID:
Pure Kana
SummaryPotency:
CBD-Total <LOQ
THC-Total <LOQ
(Reported in percent of total sample)
∆8-THC
CBGCBN
Analyte Result (%)3.41Δ8-THC†
0.711CBG†
0.00381CBN
Page 1 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
Customer: Pure KanaUnited States of America (USA)
Product identity:
04/26/21 09:30Sample Date:21-004683-0001Laboratory ID:
Client/Metrc ID: .
NoEvidence of Cooling:19.5 °CTemp:
Sample ResultsBatch: 2103911Potency Method J AOAC 2015 V98-6 (mod) Analyze: 4/29/21 6:40:00 PMUnits %
Analyte AsReceived
Dryweight
LOQ Notes
< LOQCBC 0.0033< LOQCBC-A† 0.0033< LOQCBC-Total† 0.0062< LOQCBD 0.0033< LOQCBD-A 0.0033< LOQCBD-Total 0.0062< LOQCBDV† 0.0033< LOQCBDV-A† 0.0033< LOQCBDV-Total† 0.00620.711CBG† 0.0033< LOQCBG-A† 0.00330.711CBG-Total 0.0062< LOQCBL† 0.00330.00381CBN 0.00333.41Δ8-THC† 0.0330< LOQΔ9-THC 0.0033< LOQTHC-A 0.0033< LOQTHC-Total 0.0062< LOQTHCV† 0.0033< LOQTHCV-A† 0.0033< LOQTHCV-Total† 0.00624.12Total Cannabinoids†
∆8-THC
CBGCBN
Page 2 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
1200mg Delta8+CBG Oil - Chocolate Lot 040921.D8MC.PK1
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
These test results are representative of the individual sample selected and submitted by the client.Abbreviations Limits: Action Levels per OAR-333-007-0400, OAR-333-007-0210, OAR-333-007-0220Limit(s) of Quantitation (LOQ): The minimum levels, concentrations, or quantities of a target variable (e.g., targetanalyte) that can be reported with a specified degree of confidence.
† = Analyte not NELAP accredited.
Units of Measure % = Percentage of sample% wt = µg/g divided by 10,000
Derrick TannerGeneral Manager
Approved Signatory
Page 3 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
Client signed and returned COC via email. 4/28/2021 -PG
Page 4 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
21-004683
1
2
1 2Original COC. See attached for signature. 4/28/2021 -PG
Page 5 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
21-004683
2 2
Page 6 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
Revision #: 0.00 Control : CFL-D06
Revision Date: 05/31/2019 Effective Date: 05/31/2019
J AOAC 2015 V98-6 Batch ID:Laboratory Control SampleAnalyte Spike Units % Rec Evaluation NotesCBDV-A 0.01 96.7 85.0 - 115 Acceptable
CBDV 0.01 99.2 85.0 - 115 Acceptable
CBD-A 0.01 98.8 85.0 - 115 Acceptable
CBG-A 0.01 97.3 85.0 - 115 Acceptable
CBG 0.01 100 85.0 - 115 Acceptable
CBD 0.01 111 85.0 - 115 Acceptable
THCV 0.01 100.0 85.0 - 115 Acceptable
THCVA 0.01 92.5 85.0 - 115 Acceptable
CBN 0.01 104 85.0 - 115 Acceptable
THC 0.01 100 85.0 - 115 Acceptable
D8THC 0.01 99.6 85.0 - 115 Acceptable
CBL 0.01 92.1 85.0 - 115 Acceptable
CBC 0.01 112 85.0 - 115 Acceptable
THCA 0.01 96.7 85.0 - 115 Acceptable
CBCA 0.01 96.4 85.0 - 115 Acceptable
Method BlankAnalyte LOQ Evaluation NotesCBDV-A 0.003 < Acceptable
CBDV 0.003 < Acceptable
CBD-A 0.003 < Acceptable
CBG-A 0.003 < Acceptable
CBG 0.003 < Acceptable
CBD 0.003 < Acceptable
THCV 0.003 < Acceptable
THCVA 0.003 < Acceptable
CBN 0.003 < Acceptable
THC 0.003 < Acceptable
D8THC 0.003 < Acceptable
CBL 0.003 < Acceptable
CBC 0.003 < Acceptable
THCA 0.003 < Acceptable
CBCA 0.003 < Acceptable
Abbreviations
ND - None Detected at or above MRL
RPD - Relative Percent Difference
LOQ - Limit of Quantitation
Units of Measure:
% - Percent
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
Result
0.00964
0.0100
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
<LOQ
0.003
%
%
0.003
0.003
%
%
%
0.003
0.003
0.003
Laboratory Quality Control Results2103874/2103911
Limits
%
%
%
%
%
%
%
%
%
0.00992
0.00967
Result
0.0104
0.00925
0.01000
0.0111
0.0100
0.00973
0.00988
%
Limits
%
%
0.00967
0.0112
0.00921
0.00996
%
%
%
0.003
%
%
%
%
%
%
Units
0.003
0.003
0.003
0.003
0.003
0.003
0.003
0.003
%
%
%
%
Page 7 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
Revision #: 0.00 Control : CFL-D06
Revision Date: 05/31/2019 Effective Date: 05/31/2019
Laboratory Quality Control ResultsJ AOAC 2015 V98-6 Batch ID:Sample Duplicate Sample ID:
Analyte Result Org. Result LOQ Units RPD Evaluation NotesCBDV-A <LOQ <LOQ 0.003 NA < Acceptable
CBDV 0.00950 0.00985 0.003 3.59 < Acceptable
CBD-A <LOQ <LOQ 0.003 NA < Acceptable
CBG-A <LOQ <LOQ 0.003 NA < Acceptable
CBG 0.0602 0.0609 0.003 1.23 < Acceptable
CBD 2.21 2.10 0.003 5.02 < Acceptable
THCV <LOQ <LOQ 0.003 NA < Acceptable
THCVA <LOQ <LOQ 0.003 NA < Acceptable
CBN 0.0184 0.0187 0.003 1.57 < Acceptable
THC 0.0689 0.0700 0.003 1.60 < Acceptable
D8THC <LOQ <LOQ 0.003 NA < Acceptable
CBL 0.00757 0.00672 0.003 11.8 < Acceptable
CBC 0.0792 0.0810 0.003 2.23 < Acceptable
THCA <LOQ <LOQ 0.003 NA < Acceptable
CBCA <LOQ <LOQ 0.003 NA < Acceptable
Abbreviations
ND - None Detected at or above MRL
RPD - Relative Percent Difference
LOQ - Limit of Quantitation
NA - Calculation Not Applicable given non-numerical results
Units of Measure:
% - Percent
% 20
% 20
% 20
%
21-004681-0001
% 20
% 20
20
2103874/2103911
% 20
Limits
% 20
% 20
% 20
% 20
20
% 20
%
% 20
% 20
Page 8 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:Report Date:ORELAP#:
05/04/2021OR100028
10:40Received: 04/28/21Purchase Order:
21-004683/D02.R00
Code ExplanationQ Matrix interferences affecting spike or surrogate recoveries.Q1 Quality control result biased high. Only non-detect samples reported.Q2 Quality control outside QC limits. Data considered estimate.Q3 Sample concentration greater than four times the amount spiked.Q4 Non-homogenous sample matrix, affecting RPD result and/or % recoveries.Q5 Spike results above calibration curve.Q6 Quality control outside QC limits. Data acceptable based on remaining QC.R Relative percent difference (RPD) outside control limit.R1 RPD non-calculable, as sample or duplicate results are less than five times the LOQ.R2 Sample replicates RPD non-calculable, as only one replicate is within the analytical range.LOQ1 Quantitation level raised due to low sample volume and/or dilution.LOQ2 Quantitaion level raised due to matrix interference.B Analyte detected in method blank, but not in associated samples.B1 The sample concentration is greater than 5 times the blank concentration.B2 The sample concentration is less than 5 times the blank concentration.
Explanation of QC Flag Comments:
Page 9 of 9www.columbialaboratories.com
Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Columbia Laboratories quality assurance planunless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.Testing in accordance with: OAR 333-007-0430